# EVOTAZ

NDC: 0003-3641
Generic name: atazanavir and cobicistat
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20150129

FDA application: NDA206353

## Active ingredients

- ATAZANAVIR SULFATE: 300 mg/1
- COBICISTAT: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-3641"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-3641
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83db29d7-5d85-49d6-8cb6-740473365cf8